L Dewulf

779 total citations
19 papers, 472 citations indexed

About

L Dewulf is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Economics and Econometrics. According to data from OpenAlex, L Dewulf has authored 19 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in General Health Professions and 4 papers in Economics and Econometrics. Recurrent topics in L Dewulf's work include Pregnancy and Medication Impact (6 papers), Maternal Mental Health During Pregnancy and Postpartum (5 papers) and Reproductive Health and Contraception (4 papers). L Dewulf is often cited by papers focused on Pregnancy and Medication Impact (6 papers), Maternal Mental Health During Pregnancy and Postpartum (5 papers) and Reproductive Health and Contraception (4 papers). L Dewulf collaborates with scholars based in Belgium, United States and United Kingdom. L Dewulf's co-authors include Nathan Vastesaeger, Ify Sargeant, Jan Geißler, Roslyn F. Schneider, Marc Boutin, Anton Hoos, Bert Vander Cruyssen, Filip Van den Bosch, Serge Steinfeld and Paul Van Cauwenberge and has published in prestigious journals such as Annals of the Rheumatic Diseases, Statistics in Medicine and Allergy.

In The Last Decade

L Dewulf

19 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Dewulf Belgium 10 121 119 93 86 85 19 472
William J. Waters United States 12 88 0.7× 53 0.4× 42 0.5× 85 1.0× 20 0.2× 50 437
Motolani E. Ogunsanya United States 12 46 0.4× 73 0.6× 35 0.4× 43 0.5× 66 0.8× 37 303
Costel Chirila United States 13 42 0.3× 27 0.2× 74 0.8× 29 0.3× 23 0.3× 35 423
Reginald C. S. Ho United States 9 161 1.3× 27 0.2× 68 0.7× 20 0.2× 229 2.7× 19 620
Hollie Schmidt United States 8 55 0.5× 58 0.5× 51 0.5× 95 1.1× 94 1.1× 20 413
Leena R. Baghdadi Saudi Arabia 10 19 0.2× 201 1.7× 13 0.1× 42 0.5× 28 0.3× 21 392
Nicholas Adlard Switzerland 13 41 0.3× 79 0.7× 111 1.2× 47 0.5× 77 0.9× 46 524
Catherine Bender United States 10 77 0.6× 13 0.1× 46 0.5× 71 0.8× 102 1.2× 16 462
Francis Lobo United States 11 50 0.4× 31 0.3× 41 0.4× 16 0.2× 13 0.2× 36 388
India Sisler United States 11 53 0.4× 24 0.2× 13 0.1× 52 0.6× 54 0.6× 37 523

Countries citing papers authored by L Dewulf

Since Specialization
Citations

This map shows the geographic impact of L Dewulf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Dewulf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Dewulf more than expected).

Fields of papers citing papers by L Dewulf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Dewulf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Dewulf. The network helps show where L Dewulf may publish in the future.

Co-authorship network of co-authors of L Dewulf

This figure shows the co-authorship network connecting the top 25 collaborators of L Dewulf. A scholar is included among the top collaborators of L Dewulf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Dewulf. L Dewulf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Dewulf, L, et al.. (2023). Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape Review. Therapeutic Innovation & Regulatory Science. 58(1). 63–78. 9 indexed citations
3.
Dewulf, L, et al.. (2021). Sexual violence in medical students and specialty registrars in Flanders, Belgium: a population survey. BMC Medical Education. 21(1). 130–130. 9 indexed citations
4.
Calsteren, Kristel Van, Ksenija Geršak, Ingrid Klingmann, et al.. (2016). Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG). European Journal of Obstetrics & Gynecology and Reproductive Biology. 201. 211–214. 13 indexed citations
5.
Boutin, Marc, L Dewulf, Anton Hoos, et al.. (2016). Culture and Process Change as a Priority for Patient Engagement in Medicines Development. Therapeutic Innovation & Regulatory Science. 51(1). 29–38. 38 indexed citations
6.
Calsteren, Kristel Van, Ksenija Geršak, Ingrid Klingmann, et al.. (2016). Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG). European Journal of Obstetrics & Gynecology and Reproductive Biology. 201. 189–191. 11 indexed citations
7.
Clemow, David B., et al.. (2015). Medicines in Pregnancy Forum: Proceedings on Ethical and Legal Considerations. Therapeutic Innovation & Regulatory Science. 49(3). 326–332. 2 indexed citations
8.
Hoos, Anton, James W. Anderson, Marc Boutin, et al.. (2015). Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action. Therapeutic Innovation & Regulatory Science. 49(6). 929–939. 132 indexed citations
9.
Clemow, David B., et al.. (2014). Clinical Data for Informed Medication Use in Pregnancy: Strengths, Limitations, Gaps, and a Need to Continue Moving Forward. Therapeutic Innovation & Regulatory Science. 48(2). 134–144. 2 indexed citations
10.
Dewulf, L. (2014). Patient Engagement by Pharma—Why and How? A Framework for Compliant Patient Engagement. Therapeutic Innovation & Regulatory Science. 49(1). 9–16. 23 indexed citations
11.
Clemow, David B., et al.. (2014). A Proposed Framework to Address Needs of Clinical Data for Informed Medication Use in Pregnancy. Therapeutic Innovation & Regulatory Science. 48(2). 145–154. 5 indexed citations
12.
Dewulf, L. (2013). Medicines in Pregnancy—Women and Children First? Time for a Coalition to Address a Substantial Patient Need. Therapeutic Innovation & Regulatory Science. 47(5). 528–532. 8 indexed citations
13.
Boonen, Annelies, Bert Vander Cruyssen, Kurt De Vlam, et al.. (2009). Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome. The Journal of Rheumatology. 36(6). 1249–1255. 45 indexed citations
14.
Cruyssen, Bert Vander, C. Ribbens, Herman Mielants, et al.. (2007). The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Annals of the Rheumatic Diseases. 66(8). 1072–1077. 76 indexed citations
15.
Vlam, Kurt De, Nathan Vastesaeger, Annelies Boonen, et al.. (2006). Belgian patients with familial and sporadic ankylosing spondylitis differ in disease phenotype. Ghent University Academic Bibliography (Ghent University). 54(9). 717. 2 indexed citations
16.
Hoecke, Helen Van, et al.. (2006). Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy. 61(6). 705–711. 62 indexed citations
17.
Lesaffre, Emmanuel, Geert Molenberghs, & L Dewulf. (1996). EFFECT OF DROPOUTS IN A LONGITUDINAL STUDY: AN APPLICATION OF A REPEATED ORDINAL MODEL. Statistics in Medicine. 15(11). 1123–1141. 20 indexed citations
18.
Dewulf, L, et al.. (1995). Epidemiological data of patients treated with. International Clinical Psychopharmacology. 9. 67–67. 10 indexed citations
19.
Dewulf, L, et al.. (1960). [The treatment of Hodgkin's disease].. PubMed. 16. 205–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William J. Waters Breakdown of academic impact, for papers by Motolani E. Ogunsanya Breakdown of academic impact, for papers by Costel Chirila Breakdown of academic impact, for papers by Reginald C. S. Ho Breakdown of academic impact, for papers by Hollie Schmidt Breakdown of academic impact, for papers by Leena R. Baghdadi Breakdown of academic impact, for papers by Nicholas Adlard Breakdown of academic impact, for papers by Catherine Bender Breakdown of academic impact, for papers by Francis Lobo Breakdown of academic impact, for papers by India Sisler
Rankless by CCL
2026